Contract 75N93019C00061
Greffex Inc · Department Of Health And Human Services · September 7, 2021
Greffex Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 7, 2021 for $11.25 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Seattle, WA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses cost-plus contract pricing. The most recent modification was on September 3, 2025. If all options are exercised, the contract could reach $19.12 million.
Contract details
- PIID
- 75N93019C00061
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Seattle, WA
- First action
- September 7, 2021
- Latest action
- September 3, 2025
Description
THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE 5TH YEAR FUNDS FROM LINE 6
Modification timeline
-
September 3, 2025Mod P00028 · Other Administrative Action$11.25M
-
July 24, 2024Mod P00023 · Other Administrative ActionEXTEND PERFORMANCE TIME OF OPTIONS DUE TO DELAYS IN CHANGING FROM ONE MANUFACTURING CONTRACTOR TO ANOTHER MANUFACTURING CONTRACTOR.$10.83M
-
September 29, 2023Mod P00021 · Other Administrative ActionTO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES.$9.57M
-
September 7, 2021Mod P00012 · Other Administrative ActionTO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES.$8.29M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93019C00061?
Contract 75N93019C00061 is a federal contract awarded to Greffex Inc by Department Of Health And Human Services on September 7, 2021 for $11.25 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75N93019C00061?
Greffex Inc won contract 75N93019C00061 from Department Of Health And Human Services.
How much is contract 75N93019C00061 worth?
Contract 75N93019C00061 has obligated $0 to date but carries a potential ceiling of $19.12 million if fully funded and all options are exercised.